Literature DB >> 2718750

Some characteristics of patients given dental treatment under general anesthesia.

J Grytten1, D Holst, L Dyrberg, O Faehn.   

Abstract

The attitude to treatment of dental diseases under general anesthesia has been rather restricted in the dental profession in Scandinavia. Yet, some patients with certain medical conditions and patients haunted by anxiety may not be able to have conventional dental treatment. During the period 1975-1983, 1067 patients were treated in a group practice in Oslo. These patients are described with regard to gender, age, reasons for treatment, place of residence, source of referral, and type of treatment given. Some of the data are related to the year of treatment. The profile of patients changed during the observation period. At the beginning most of the patients came from Oslo and were less than 6 years old, whereas at the end most of the patients were more than 15 years old, lived outside Oslo, and had more conservative than radical treatment. It is concluded that there will probably always be a small group for whom dental treatment under general anesthesia will be necessary.

Entities:  

Mesh:

Year:  1989        PMID: 2718750     DOI: 10.3109/00016358909004793

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  3 in total

1.  A retrospective study of deep sedation with concomitant administration of sedative agents in children undergoing surgical removal of a mesiodens.

Authors:  Soo Jeong Lee; Kwangwoo Baek
Journal:  J Dent Anesth Pain Med       Date:  2015-12-31

2.  Five-year follow-up of children receiving comprehensive dental care under general anesthesia.

Authors:  Nora Savanheimo; Miira M Vehkalahti
Journal:  BMC Oral Health       Date:  2014-12-15       Impact factor: 2.757

3.  Dental care and treatments provided under general anaesthesia in the Helsinki Public Dental Service.

Authors:  Nora Savanheimo; Sari A Sundberg; Jorma I Virtanen; Miira M Vehkalahti
Journal:  BMC Oral Health       Date:  2012-10-27       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.